NeuroSense Therapeutics (NRSN) Inventory (2024 - 2025)
NeuroSense Therapeutics (NRSN) posted Inventory of $452000.0 for Q4 2025, down 38.75% sequentially from $738000.0 in Q4 2024, and down 38.75% YoY from $738000.0 in Q4 2024.
NeuroSense Therapeutics (NRSN) Inventory (2024 - 2025) Analysis & Trends
NeuroSense Therapeutics has reported Inventory for 2 years, with the latest figure at $452000.0 in Q4 2025.
- Quarterly Inventory fell 38.75% year-over-year to $452000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $452000.0 (down 38.75% YoY) and the FY2025 annual result came in at $452000.0, down 38.75% from the prior year.
- Inventory fell to $452000.0 in Q4 2025 per NRSN's latest filing, from $738000.0 in the prior quarter.
- Over five years, Inventory peaked at $738000.0 in Q4 2024 and troughed at $452000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - | 452,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 738,000.00 |